This study is testing KarXT, a possible treatment for psychosis (seeing or hearing things that aren't there) linked to Alzheimer's Disease (AD), a brain disorder that affects memory. The goal is to see if KarXT is safe and works well in adults who have mild to severe AD and moderate to severe psychosis. Participants will be between 55 and 90 years old and must have a brain scan like an MRI or CT within the past 5 years to rule out other brain diseases. They also need to have had psychotic symptoms for at least two months.
Key Points:
- Participants must be between the ages of 55 to 90 and have had psychotic symptoms for at least 2 months.
- Participants need a brain scan (MRI or CT) completed within the past 5 years.
- People with other mental health conditions or certain lab test irregularities are not eligible.
If you think you fit the criteria and are interested in joining, more specific rules apply, and you should talk to the study team or your doctor.
How understandable was the trial content above?
Hard to understand
Easy to understand